MGPT was performed after her colon cancer had negative IHC staining for MSH6, and confirmed a germline mutation in MSH6, while revealing additional mutations in BAP1 and RECQL4 genes (Table 1, Fig. 1). This evidence concerns the gene BAP1 and malignant colon neoplasm.